We are live on
!
Find out more
OM
Opaleye Management Portfolio holdings
AUM
$758M
1-Year Est. Return
124.8%
This Fund
S&P 500
This Quarter
Est. Return
+13.93%
1 Year Est. Return
+124.8%
3 Year Est. Return
+486.05%
5 Year Est. Return
+742.19%
10 Year Est. Return
+62,231.09%
AUM
$494M
AUM Growth
+$45M
(+10%)
Cap. Flow
+$16.8M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
73.47%
Holding
50
New
5
Increased
15
Reduced
12
Closed
9
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
+$21.3M |
| 2 |
Codexis
CDXS
|
+$7.27M |
| 3 |
Larimar Therapeutics
LRMR
|
+$5.08M |
| 4 |
Disc Medicine
IRON
|
+$4.76M |
| 5 |
VIGL
Vigil Neuroscience
VIGL
|
+$4.48M |
Top Sells
| 1 |
Ginkgo Bioworks
DNA
|
+$5.38M |
| 2 |
PVLA
Palvella Therapeutics
PVLA
|
+$4.82M |
| 3 |
AnaptysBio
ANAB
|
+$4.66M |
| 4 |
SLRN
ACELYRIN
SLRN
|
+$3.99M |
| 5 |
Protara Therapeutics
TARA
|
+$3.02M |
Sector Composition
| 1 | Healthcare | 97.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Harrow
HROW
$1.55B
| $119M | 24.13% |
3,905,000
-50,000
| -1% | -$1.34M |
|
2
Eton Pharmaceutcials
ETON
$1.03B
| $40.8M | 8.25% |
2,860,000
+7,930
| +0.3% | +$125K |
|
3
Immunome
IMNM
$2.59B
| $32.8M | 6.64% |
3,529,581
-20,419
| -0.6% | -$167K |
|
|
SNWV
4
SANUWAVE Health Inc
SNWV
$103M
| $32.2M | 6.52% |
980,000
+7,998
| +0.8% | +$242K |
|
5
Liquidia Corp
LQDA
$6.74B
| $30.8M | 6.24% |
2,475,000
+215,000
| +10% | +$3.18M |
|
|
6
Codexis
CDXS
$199M
| $30.7M | 6.22% |
12,600,000
+3,100,000
| +33% | +$7.27M |
|
7
Rhythm Pharmaceuticals
RYTM
$7.49B
| $30M | 6.07% |
475,000
-15,000
| -3% | -$918K |
|
8
TG Therapeutics
TGTX
$8.44B
| $19.3M | 3.9% |
535,000
| – | – |
|
9
Ocular Therapeutix
OCUL
$2.14B
| $14.8M | 3% |
1,595,000
| – | – |
|
10
Arvinas
ARVN
$532M
| $12.4M | 2.5% |
1,680,000
-295,000
| -15% | -$2.17M |
|
|
11
Larimar Therapeutics
LRMR
$385M
| $11.9M | 2.4% |
4,110,000
+2,195,923
| +115% | +$5.08M |
|
|
12
Disc Medicine
IRON
$2.86B
| $9.87M | 2% |
186,418
+101,418
| +119% | +$4.76M |
|
|
13
Sarepta Therapeutics
SRPT
$1.92B
| $8.55M | 1.73% |
+500,000
| New | +$21.3M |
|
|
VIGL
14
DELISTED
Vigil Neuroscience
VIGL
| $7.95M | 1.61% |
+1,000,000
| New | +$4.48M |
|
15
CG Oncology
CGON
$6.29B
| $6.92M | 1.4% |
266,000
+102,012
| +62% | +$2.46M |
|
16
Xoma
XOMA
$710M
| $6.43M | 1.3% |
255,087
+2,044
| +0.8% | +$49K |
|
17
Edgewise Therapeutics
EWTX
$4.29B
| $6.42M | 1.3% |
490,000
+95,000
| +24% | +$1.37M |
|
18
Stoke Therapeutics
STOK
$1.82B
| $6.38M | 1.29% |
562,120
+262,120
| +87% | +$2.49M |
|
19
Anika Therapeutics
ANIK
$207M
| $6.23M | 1.26% |
588,797
+193,797
| +49% | +$2.45M |
|
20
Protagonist Therapeutics
PTGX
$8.33B
| $5.8M | 1.17% |
105,000
| – | – |
|
|
21
Ginkgo Bioworks
DNA
$592M
| $5.63M | 1.14% |
500,000
-695,000
| -58% | -$5.38M |
|
22
Gossamer Bio
GOSS
$65M
| $4.36M | 0.88% |
3,545,000
-742,415
| -17% | -$810K |
|
23
Rezolute
RZLT
$464M
| $4.03M | 0.82% |
903,442
+438,442
| +94% | +$1.63M |
|
24
Revolution Medicines
RVMD
$39.3B
| $3.86M | 0.78% |
+105,000
| New | +$4.03M |
|
|
EPIX
25
DELISTED
ESSA Pharma
EPIX
| $3.76M | 0.76% |
2,209,998
| – | – |
|
Similar funds
WCFA
SIG
GWM
IAS
TVAMP
RFM
MWA
CFS